Eye on FDA

MAY 19, 2020

COVID-19 was a shock to the system unlike anything that had been anticipated. Even prior to the shutdown, health-perceptive people were starting to avoid public venues and there were declines in the numbers of people going out to eat at restaurants, to public functions, visiting with friends and also going to the doctor’s offices. When it comes to healthcare, that has translated into multiple stress points to our system of care spanning both health and economics with people avoiding care f

Communication 54

Communication Inpatient Hospitals 54

Drug Channels

MAY 21, 2020

In Copay Maximizers Are Displacing Accumulators—But CMS Ignores How Payers Leverage Patient Support , I explained a new Centers for Medicare and Medicaid Services (CMS) final rule regarding health plans’ use of copay accumulator adjustment. I also highlighted why plans have responded to the negative patient impact from accumulators with copay maximizer programs.

52

52

Pharma Packaging Solutions

MAY 21, 2020

As the situation with COVID-19 continues to change, we wanted to let you know that Carton Service/Pharma Packaging Solutions is defined as an Essential Industry due to the life-sustaining products we produce. Even with communities establishing Shelter-In-Place or Safer-At-Home orders, our associates have been notified that they are essential workers.

Packaging 52

Packaging 52

Pharmacy Joe

MAY 20, 2020

In this episode, I’ll discuss the pharmacist’s role if malignant hyperthermia is suspected outside of the operating room. Episode 506: The pharmacist's role if malignant hyperthermia is suspected outside of the operating room Subscribe on iTunes , Android , or Stitcher Malignant hyperthermia is a rare event, occurring in about 1 out of 100,000 administrations of anesthesia.

Hospitals 40

Hospitals Inpatient 40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

MAY 20, 2020

I stumbled into this article a while ago regarding Nuedexta off-label fraud for behavioral issues involving dementia patients in long term care facilities. It makes me sad and frustrated. I’d like to make a couple of points. Nuedexta Off-Label Evidence in Dementia The evidence of Nuedexta being beneficial in this patient population for the off-label […].

Labelling 40

Labelling Long-Term Care Facilities 40

Drug Channels

MAY 19, 2020

COVID-19 has not stopped the wheels of policy bureaucracy from grinding. Last week, the Centers for Medicare and Medicaid Services (CMS) released its final Notice of Benefit and Payment Parameters for the 2021 benefit year. You’ll find the document links below. This final rule permits insurers to exclude the value of a pharmaceutical manufacturer’s copay support program from a patient’s annual deductible and out-of-pocket maximum obligations.

Documentation 52

Documentation 52

Pharmacy Joe

MAY 17, 2020

In this episode, I’ll discuss a new observation study on hydroxychloroquine and Covid-19. Episode 505: New observational data on hydroxychloroquine and Covid-19 Subscribe on iTunes , Android , or Stitcher Article Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 Lead author: Joshua Geleris Published in New England Journal of Medicine May 2020 Background Following reports from China and South Korea, and then a small French cohort of patients, hydroxychloroquine has

Hospitals 40

Hospitals Inpatient 40

Med Ed 101

MAY 17, 2020

Geriatrics can get very complicated very fast. Chronic conditions, polypharmacy, and drug interactions are a few of the many complications. Here are a few things that make me think twice in geriatric patients. Multiple Medication Changes As I reveiw a patient’s medication list, I review recent changes that have been made. The more changes that […].

40

40

Drug Channels

MAY 22, 2020

Today’s guest post comes from Kyle Grimslid, Market Development Director at CoverMyMeds. Kyle describes the complications that providers and patients encounter in the specialty prescription process. He describes how AMP: Access for more Patients™ enhances access, affordability and adherence—including a reported 27% reduction in time to therapy. Click here to learn more about how CoverMyMeds and RxCrossroads by McKesson are using technology to solve patients' medication access challenges.

Prescription Management 40

Prescription Management 40